IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer
Among patients with first-line pancreatic cancer, treatment of IMM-1-104 in combination with modified Gemzar plus Abraxane (gemcitabine plus nab-paclitaxel, mGnP) demonstrated both efficacious and tolerable outcomes in an ongoing phase 2a trial, according …